Germ-Line Gene Therapy and the Medical Imperative
- 1 June 1992
- journal article
- research article
- Published by Project MUSE in Kennedy Institute of Ethics Journal
- Vol. 2 (2) , 137-158
- https://doi.org/10.1353/ken.0.0091
Abstract
Somatic cell gene therapy has yielded promising results. If germ cell gene therapy can be developed, the promise is even greater: hundreds of genetic diseases might be virtually eliminated. But some claim the procedure is morally unacceptable. We thoroughly and sympathetically examine several possible reasons for this claim but find them inadequate. There is no moral reason, then, not to develop and employ germ-line gene therapy. Taking the offensive, we argue next that medicine has a prima facie moral obligation to do so.Keywords
This publication has 12 references indexed in Scilit:
- Cloning of the essential myotonic dystrophy region and mapping of the putative defectNature, 1992
- Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophyNature, 1992
- Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophyNature, 1992
- Germ-line Gene Therapy: A New Stage of DebateLaw, Medicine and Health Care, 1992
- Human Gene Therapy and CongressHuman Gene Therapy, 1990
- Human Gene Therapy: Must We Know Where to Stop Before We Start?Human Gene Therapy, 1990
- Normative NaturalismPhilosophy of Science, 1990
- Why Medicine Cannot be a ScienceJournal of Medicine and Philosophy, 1981
- Genetics and American Society: A Historical AppraisalThe American Historical Review, 1974
- Foundations of the Metaphysics of Morals. What is Enlightenment? And a Passage from the Metaphysics of Morals.The Journal of Philosophy, 1951